Moneycontrol » News » Stocks » Expert Advice

Buy Glenmark Pharma: Sukhani

Published on Sat, Nov 21, 2009 at 09:58 |  Source : CNBC-TV18

Updated at Sat, Nov 21, 2009 at 14:27  

22007 Investors following Glenmark. Share this News with them.
0
0
Share on Tumblr
Sudarshan Sukhani, Technical Analyst

Excerpts from Your Stocks on CNBC-TV18 Watch the full show ยป

ALSO READ

Glenmark

BSE | NSE 10/02/12

Buy Glenmark Pharma , says Technical Analyst, Sudarshan Sukhani.

Sukhani told CNBC-TV18, "Stocks that slowly start going up come into my list of stocks that I want to buy and Glenmark qualifies. So I would say if you own it hold it, if you want to buy this is as good a time as any to buy. You can look at Rs 280 or 315 as short term targets, which is a pretty decent percentage gain, so it is worth buying."

  

PREVIOUS STORY

Buy JK Lakshmi Cement: PPFAS

NEXT STORY

TCS to expand centers in N.America; CY12 focus on Japan

Entities: Sudarshan Sukhani, Sudarshan Sukhani, Sudarshan Sukhani, Sudarshan Sukhani
More on Moneycontrol
Headlines
view all »
20% rally in 40 days: Is this a bull market!
04:05 PM
20% rally in 40 days: Is this a bull market!
'India needs to be self reliant for economic growth'
10:23 AM
'India needs to be self reliant for economic growth'
See more rally even if Greek crisis drags on: RBS
04:00 PM
See more rally even if Greek crisis drags on: RBS
RIL's KG-D6 may see a further dip in output
11:07 AM
RIL's KG-D6 may see a further dip in output
Video of the day
'5200 strong support for mkt, next resistance at 5500-5550'
play
09:56 AM
'5200 strong support for mkt, next resistance at 5500-5550'
- in FII View
Sensex logs 6th week of gain, ends day with 85 pts loss
Listen Now!
Slideshows

Trending News

Business News

Tags: Technical Analyst, Sudarshan Sukhani, Glenmark Pharma
Logitech ZAAG iPad2 Keyboard Case
Competition ahoy: Monkey 1, Sensex in neck-and-neck race "Competition ahoy: Monkey 1, Sensex in neck-and-neck race"

News

From DJ Greek Fin Min Says Feb 17 Final Day For Greek Bond Exchange Offer

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 12 2012, 11:20

See more rally even if Greek crisis drags on: RBS

- in FII View

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 11 2012, 11:52 | Source: CNBC-TV18

TCS to expand centers in N.America; CY12 focus on Japan  

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com

Explore Moneycontrol

STOCKS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
MUTUAL FUNDS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News | Markets | IPO | Technicals | Mutual Fund | Commodities | Best Portfolio Manager | Bse Sensex | Bombay Stock Exchange | Share Market Live | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | National Stock Exchange | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds | Unit Linked Insurance Plans (ULIPs) | | Budget: 2008, 2009, 2010, 2011, 2012 |  Intuit Money Manager | RBI Credit Policy | Union Budget | Budget 2012  | Economic Survey  | Railway Budget  | Financial Glossary  |  Message Board | Moneybhai | Connect.in.com | Business Yellow Pages | India's Premiere Technology Guide | History India  | Up Polls |  Latest News  | Uninor | Aurobindo Pharma | Niko Resources | Vodafone Essar | Suzlon Energy | Etisalat | Tata Steel | National missile defense | Search Engines | Acropolis
Site Map  |  About Us  |  Contact Us  |  Advertise  |  Bookmark  |  Disclaimer  |  Privacy Statement  |  Terms of Use  |  Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.